Pancreatic Cancer Research

ResearcherUniversità Cattolica del Sacro CuoreNo recent work listed

Savino Cilla Phys

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0001-6711-350X; OpenAlex author ID A5000531166. Sources: OpenAlex.

Their work

Papers
9
Trials
0
Grants
0
Labs led
0
Collaborators
31
Papers, trials and grants by year

2012: 1 paper · 2013: none · 2014: none · 2015: none · 2016: none · 2017: none · 2018: none · 2019: 2 papers · 2020: 3 papers · 2021: 1 paper · 2022: 1 paper · 2023: 1 paper

Papers 9

  1. Comparative Effectiveness of Chemotherapy Alone Versus Radiotherapy-Based Regimens in Locally Advanced Pancreatic Cancer: A Real-World Multicenter Analysis (PA… Co-author DOI 10.3390/curroncol30060427↗
  2. Pain Relief after Stereotactic Radiotherapy of Pancreatic Adenocarcinoma: An Updated Systematic Review. Co-author DOI 10.3390/curroncol29040214↗
  3. Definition of Local Recurrence Site in Resected Pancreatic Adenocarcinoma: A Multicenter Study (DOLORES-1). Co-author DOI 10.3390/cancers13123051↗
  4. Automated treatment planning as a dose escalation strategy for stereotactic radiation therapy in pancreatic cancer. Co-author DOI 10.1002/acm2.13025↗
  5. Stereotactic body radiotherapy vs conventionally fractionated chemoradiation in locally advanced pancreatic cancer: A multicenter case-control study (PAULA-1). Co-author DOI 10.1002/cam4.3330↗
  6. Higher Biologically Effective Dose Predicts Survival in SBRT of Pancreatic Cancer: A Multicentric Analysis (PAULA-1). Co-author DOI 10.21873/anticanres.13975↗
  7. Radiotherapy of pancreatic cancer in older patients: A systematic review. Co-author DOI 10.1016/j.jgo.2018.09.007↗
  8. Adjuvant chemoradiation in pancreatic cancer: impact of radiotherapy dose on survival. Co-author DOI 10.1186/s12885-019-5790-2↗
  9. Clinical target volume delineation including elective nodal irradiation in preoperative and definitive radiotherapy of pancreatic cancer. Co-author DOI 10.1186/1748-717x-7-86↗

Closest collaborators

The 25 strongest of 31 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Alessio Giuseppe Morganti · 9 shared papers, 2012–2023 · strength 0.84
  2. Gabriella Macchia · 9 shared papers, 2012–2023 · strength 0.84
  3. Milly Buwenge · 8 shared papers, 2019–2023 · strength 0.81
  4. Alessandra Arcelli · 7 shared papers, 2019–2023 · strength 0.71
  5. Francesco Cellini · 6 shared papers, 2019–2023 · strength 0.61
  6. S. Cammelli · 5 shared papers, 2019–2022 · strength 0.53
  7. Lidia Strigari · 3 shared papers, 2021–2023 · strength 0.38
  8. Mariacristina Di Marco · 4 shared papers, 2019–2023 · strength 0.37
  9. Michele Fiore · 3 shared papers, 2020–2023 · strength 0.31
  10. Renzo Mazzarotto · 3 shared papers, 2020–2023 · strength 0.30
  11. Nicola Simoni · 3 shared papers, 2020–2023 · strength 0.30
  12. Gian Carlo Mattiucci · 3 shared papers, 2019–2023 · strength 0.28
  13. Vincenzo Valentini · 3 shared papers, 2012–2020 · strength 0.20
  14. Riccardo Casadei · 2 shared papers, 2019–2020 · strength 0.16
  15. Matteo Renzulli · 1 shared paper, 2021 · strength 0.10
  16. A. Sainato · 1 shared paper, 2021 · strength 0.10
  17. Domenico Genovesi · 1 shared paper, 2021 · strength 0.10
  18. Selena Ciabatti · 1 shared paper, 2019 · strength 0.09
  19. Elisa Grassi · 1 shared paper, 2020 · strength 0.09
  20. William F. Regine · 1 shared paper, 2019 · strength 0.07
  21. Felipe Ángel Calvo Manuel · 1 shared paper, 2019 · strength 0.07
  22. Lorenzo Fuccio · 1 shared paper, 2019 · strength 0.07
  23. Robert Clell Miller · 1 shared paper, 2019 · strength 0.07
  24. Paolo Passoni · 1 shared paper, 2019 · strength 0.07
  25. Sergio Alfieri · 1 shared paper, 2019 · strength 0.07

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.